According to a recent research, survivors of cancer diagnosed before the age of 25 had more than two-fold increased risk of suicide as compared to their non-cancer peers.
Published in the International Journal of Cancer, the research was conducted at the University of Burgen.
"From our study, it is not possible to say whether there is a connection between the cancer diagnosis and suicide on an individual level, but what we see is an association at population level," said the lead researcher, Winther Gunnes.
The results are based on a linkage between several national registries, including the Norwegian Cause of Death Registry and the Cancer registry of Norway.
Among the 1.2 million people born in Norway between 1965 and 1985, a total of 5,440 individuals received a cancer diagnosis before the age of 25, and these two groups were compared.
They were all tracked until 2008. During follow-up, a total of 24 of the cancer survivors committed suicide.
"Survivors of brain tumours, leukaemia, bone and soft tissue sarcomas and testicular cancer are, in our material, more vulnerable in terms of risk of suicide," Gunnes pointed out.
There was, however, no increased risk of external causes of death when one excluded suicide, like traffic accidents and accidental poisoning, among others.
However, Gunnes' research could not look at the individual background of this increased suicide risk.
This can be a result of the total chronic health burden, which is something many survivors have to live with for years, often life-long, after treatment is completed.
Often, these survivors do not know where to turn to for help, and they might not find the right help.
"We do not have any proper follow-up system for adult long time survivors of young age cancer," Gunnes said.
She pointed out that the absolute risk of committing suicide for cancer survivors is low and that one of the drawbacks of the study is the low numbers of suicide in total.
"It is, however, important to be aware of these new findings in order to develop appropriate surveillance and intervention strategies as part of a long-term follow-up programme of these cancer survivors," she concluded.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
